V23-6-jD: Prädiktiver Einfluss unterschiedlicher histologischer Subtypen auf die lokale Kontrolle nach stereotaktischer Bestrahlung (SBRT) von Lungenmetastasen bei Patienten mit nicht-kleinzelligem Bronchialkarzinom (NSCLC) im oligo-metastasierten Stadium [Abstract]

Autor: Hörner-Rieber, J., Blanck, O., Boda-Heggemann, J., Duma, M., Eble, M. J., Eich, H. T., Flentje, M., Gerum, S., Hass, P., Henkenberens, C., Herold, H.-U., Hildebrandt, G., Imhoff, D., Janssen, S., Kahl, Klaus-Henning, Klass, N. D., Krempien, R., Lautenschläger, S. F., Lohaus, F., Petersen, C., Sackerer, I., Schrade, E., Uhlmann, L., Wittig, A., Guckenberger, M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3341::afbaac9c5a6c41a166634dd88277430a
https://opus.bibliothek.uni-augsburg.de/opus4/files/76977/76977.pdf

Repeat sbrt for pulmonary oligo-metastases

Autor: Guckenberger, M., Klement, R., Rieber, J., Adebahr, S., Andratschke, N., Blanck, O., Boda-Heggemann, Judit, Duma, M., Eble, Michael J., Eich, H. T., Flentje, M., Gerum, S., Hass, P., Henkenberens, C., Hildebrandt, G., Imhoff, D., Kahl, H., Klass, N. D., Krempien, R., Lohaus, F., Petersen, C., Schrade, E., Wendt, T. G., Wittig, A.

Publikováno v: Radiotherapy and oncology 127(Supplement 1), PV-044 (2018). doi:10.1016/S0167-8140(18)30354-2 special issue: "ESTRO 37, April 20-24, 2018, Barcelona, Spain"
ESTRO 37, Barcelona, Spanien, 2018-04-20-2018-04-24

Radiotherapy and oncology 127(Supplement 1), PV-044 (2018). doi:10.1016/S0167-8140(18)30354-2 special issue: "ESTRO 37, April 20-24, 2018, Barcelona, Spain"
Published by Elsevier Science, Amsterdam [u.a.]

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d82b4ae33822829bca624094506164
https://publications.rwth-aachen.de/record/730423

Multiple Myeloma-Associated Amyloidoma of the Sacrum: Case Report and Review of the Literature

Autor: Klenke, F. M., Wirtz, C., Banz, Y., Keel, M. J. B., Klass, N. D., Novak, U., Benneker, L. M.

Publikováno v: Global Spine Journal; June 2014, Vol. 4 Issue: 2 p109-114, 6p

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease.

Autor: Tanadini-Lang S; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland., Rieber J; Department of Radiation Oncology, University Hospital Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Germany., Filippi AR; Department of Oncology, University of Torino, Torino, Italy., Fode MM; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Streblow J; Department of Radiation Oncology, University Hospital Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Germany., Adebahr S; Department of Radiation Oncology, University Hospital Freiburg, Germany., Andratschke N; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland; Department of Radiation Oncology, University of Rostock, Germany., Blanck O; Department of Radiation Oncology, UKSH Universitätsklinikum Schleswig Holstein, Kiel, Germany., Boda-Heggemann J; Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany., Duma M; Department of Radiation Oncology, Technical University Munich, Germany., Eble MJ; Department of Radiation Oncology, University Hospital Aachen, Germany., Ernst I; Department of Radiation Oncology, University Hospital Münster, Germany., Flentje M; Department of Radiation Oncology, University Hospital Wuerzburg, Germany., Gerum S; Department of Radiation Oncology, 11 Ludwig Maximilians University Munich, Germany., Hass P; Department of Radiation Oncology, University Hospital Magdeburg, Germany., Henkenberens C; Department of Radiotherapy and Special Oncology, Medical School Hannover, Germany., Hildebrandt G; Department of Radiation Oncology, University of Rostock, Germany., Imhoff D; Department of Radiation Oncology, University Hospital Frankfurt, Germany., Kahl H; Department of Radiation Oncology, Hospital Augsburg, Germany., Klass ND; Department of Radiation Oncology, Bern University Hospital, Bern, Switzerland., Krempien R; Department of Radiation Oncology, Helios Klinikum Berlin Buch, Germany., Lohaus F; Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg Germany and German Cancer Consortium (DKTK), Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology (NCRO), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany., Petersen C; Department of Radiation Oncology, University Hospital Hamburg, Germany., Schrade E; Department of Radiation Oncology, Hospital Heidenheim, Germany., Wendt TG; Department of Radiation Oncology, University Hospital Jena, Germany., Wittig A; Department of Radiotherapy and Radiation Oncology, Philipps-University Marburg, University Hospital Giessen and Marburg, Germany., Høyer M; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Ricardi U; Department of Oncology, University of Torino, Torino, Italy., Sterzing F; Department of Radiation Oncology, University Hospital Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Germany; German Cancer Research Center, Clinical Cooperation Unit Radiation Oncology, Heidelberg, Germany., Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland. Electronic address: matthias.guckenberger@usz.ch.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2017 May; Vol. 123 (2), pp. 182-188. Date of Electronic Publication: 2017 Feb 04.